Nicotinamide in Glaucoma (NAMinG): a randomised, placebo-controlled, multicentre, Phase III trial

Project: Research

Project Details

AcronymNAMing trial
StatusActive
Effective start/end date1/12/2021 → 30/11/2026

Collaborative partners

  • King's College London
  • Cardiff University
  • KCH King's College Hospital NHS Foundation Trust
  • University College London (lead)

Funding

  • NIHR National Institute For Health & Care Research: £8,739.47